Ovid Therapeutics Inc (OVID)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
468,715,000
EV to revenue ratio (TTM)
252.17
EV to ebitda
-0.691
Financial Performance
Revenue (TTM)
1,583,000
Gross profit (TTM)
1,583,000
EBITDA
-57,974,000
Profitability
Operating margin (TTM)
-2,101.00%
Profit margin
0.00%
Return on assets (TTM)
-23.50%
Return on equity (TTM)
-26.00%
Per Share Metrics
Revenue per share (TTM)
0.01
EPS
-0.21
Diluted EPS (TTM)
-0.21
Book value
1.14
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
1.792
PEG ratio
0
Price to sales ratio (TTM)
296.09
Price to book ratio (TTM)
2.4
Growth
Quarterly earnings growth (YoY)
-88.30%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
10
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.249